Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 1401–1450 of 18616
Pursuant to the Separation Agreement, Mr. Wise resigned from all of his positions with the Company, including his positions as Chief Executive Officer, Chairman of the Board, and director.
appointed Rahul Patel as President and Chief Executive Officer of the Company, and as a member of the Board
Mr. Patel succeeds the Company's Chief Financial Officer, Ken Rizvi, who has served as the Company’s Interim Chief Executive Officer since February 2025.
Robert Bodor, who ceased to be the President and Chief Executive Officer and a director of the Company effective as of the Transition Date.
the Board of Directors (the “Board”) of the Company has appointed Suresh Krishna to serve as the Company’s President and Chief Executive Officer, effective May 20, 2025
On May 20, 2025, the Company appointed Akhil Mahendra as interim Chief Financial Officer of the Company, effective May 30, 2025, to hold the position of interim Chief Financial Officer until his successor is appointed.
On May 19, 2025, Abhishek Khandelwal, Senior Vice President and Chief Financial Officer of IDEX Corporation (the “Company”), notified the Company of his decision to resign from his position, effective May 30, 2025, to pursue a new professional opportunity.
Farouq Tuweiq (“ Mr. Tuweiq ”), Bel’s current Chief Financial Officer (“ CFO ”), principal financial officer and Treasurer, was appointed to succeed Daniel Bernstein as the Company’s President and Chief Executive Officer, effective immediately following the Company’s 2025 Annual Meeting
On May 20, 2025, the Board appointed Lynn Hutkin (“ Ms. Hutkin ”), currently Bel’s Vice President of Financial Reporting and Investor Relations, as the Company’s new CFO, effective immediately following the 2025 Annual Meeting
Effective the same date, the Board of Directors appointed Vighnesh Dabole as Chief Executive Officer, President, Chief Financial Officer, Secretary, Treasurer, and sole director of the Company.
Effective May 20, 2025, Frank Gomez resigned as Chief Executive Officer, President, Chief Financial Officer, Secretary, Treasurer, and sole director of the Company.
Effective as of the date of the 2025 Annual Meeting, Kaes Van’t Hof, former President of the Company, succeeded Mr. Stice as Chief Executive Officer.
Beginning on the Effective Date, David A. Lunin will no longer serve as the Company’s principal accounting officer. Mr. Lunin will continue to serve as the Executive Vice President, Chief Financial Officer and principal financial officer of the Company.
Mark Dmytruk, the Company’s Chief Financial Officer and principal financial officer, gave notice on May 19, 2025 of his intention to resign from these roles at the Company on May 30, 2025 to accept a position at another organization
Steven Coen, CPA, the Company’s Chief Accounting Officer, will become Chief Financial Officer, principal financial officer and principal accounting officer, effective upon Mr. Dmytruk’s resignation
Effective May 15, 2025, the Company appointed Alan Weichselbaum as the Chief Financial Officer of the Company.
Effective May 16, 2025, Michelle Yanez and the Company mutually agreed to release Ms. Yanez from her position as Chief Financial Officer, Treasurer and Secretary of MIRA Pharmaceuticals, Inc. (the “Company”), effective on that date.
Effective May 16, 2025, Michelle Yanez and the Company mutually agreed to release Ms. Yanez from her position as Chief Financial Officer, Treasurer and Secretary of Telomir Pharmaceuticals, Inc. (the “Company”), effective on that date.
On May 15, 2025, the Company entered into an Employment Agreement (the “Employment Agreement”) with Mr. Weichselbaum to serve as chief financial officer of the Company beginning on May 19, 2025 (the “Start Date”).
On May 20, 2025, the Company announced the appointment of Ms. Helena Santos as its interim CFO until a suitable candidate can be appointed by the Company’s Board of Directors.
Nicholas Lavacca, who had served as the Company’s CFO since April 18, 2025, left the Company on May 19, 2025 to pursue other opportunities.
As of the Effective Date, Ariel Szarfsztejn, the Company’s current Commerce President, will become President and Chief Executive Officer of the Company.
the Company appointed Mr. Walters, the Company's current Chief Financial Officer and Treasurer, to the position of Chief Executive Officer upon the retirement of Eric W. Thornburg as Chief Executive Officer and President of the Company, each effective July 1, 2025.
upon the retirement of Eric W. Thornburg as Chief Executive Officer and President of the Company, each effective July 1, 2025.
Allison E. Marino, the Company’s Executive Vice President, Chief Financial Officer, previously served as principal accounting officer and will continue to serve as the Company’s principal financial officer.
the Board appointed and elected John M. Zaranec III as Executive Vice President and Chief Financial Officer, also effective June 16, 2025.
Messrs. Erik B. Nordstrom and Peter E. Nordstrom entered into agreements with the Company pursuant to which they assumed the roles of Co-Chief Executive Officers of the Company
Messrs. Erik B. Nordstrom and Peter E. Nordstrom entered into agreements with the Company pursuant to which they assumed the roles of Co-Chief Executive Officers of the Company
On May 16, 2025 (the “Effective Date”), the Board of Directors (the “Board”) of Schrödinger, Inc. (the “Company”) appointed Richie Jain as Executive Vice President and Chief Financial Officer and Treasurer of the Company, effective immediately.
replacing Gary Quin, who remains the Company’s Chief Executive Officer and Chairman of the Board of Directors.
Joseph W. Pooler, Jr. became the Company’s Chief Financial Officer, replacing Gary Quin, who remains the Company’s Chief Executive Officer and Chairman of the Board of Directors.
Effective May 16, 2025, Matthew Teinert resigned as Chief Financial Officer of High Roller Technologies, Inc. (the “Company”).
On May 16, 2025, the Board of Directors (the “Board”) of the Company appointed Adam Felman (age 34) as Chief Financial Officer of the Company.
Rich Walker ceased to serve as the Company’s Chief Financial Officer effective as of the Transition Date
On May 15, 2025, the Board of Directors (“ Board ”) of Skillsoft Corp. (the “ Company ”) appointed John Frederick as the Company’s Chief Financial Officer, effective as of May 15, 2025
On May 19, 2025, the Board of Directors (the “ Board ”) of enVVeno Medical Corporation (the “ Company ”) appointed Jennifer Bright as Chief Financial Officer of the Company.
On May 19, 2025, Craig Glynn resigned as Chief Financial Officer of the Company.
Mr. Morrison was appointed, effective immediately, as a member of the board of directors of the Company as well as the Company’s Chief Financial Officer and Treasurer.
On May 16, 2025, President and CEO of the Company, David S. Silverman, age 64, informed the Board of Directors of his intention to retire from the Company during 2026.
On May 15, 2025, the Company appointed Ermelinda Berberi, the Company’s Senior Vice President, Chief Accounting Officer, as Executive Vice President, Chief Financial Officer and Treasurer.
On May 15, 2025, Paramount Group, Inc. (the “Company” or “Paramount Group”) announced that Wilbur Paes, the Company’s Chief Operating Officer, Chief Financial Officer and Treasurer, and Gage Johnson, Senior Vice President, General Counsel and Secretary, will leave their positions with the Company and/or the Company’s affiliates or subsidiaries, including Paramount Group Operating Partnership LP, as applicable, effective immediately.
the Board appointed Matthew J. Simmes as the Company’s President and Chief Executive Officer and as a member of the Board, effective July 1, 2025, succeeding Jeffrey L. Gendell.
On May 18, 2025, the Board, upon the recommendation of the Nominating and Governance Committee (“NGC”), elected Henry E. Monroy, Vice President, Regulatory, of TXNM’s wholly-owned utility subsidiary, Public Service Company of New Mexico (“PNM”), as TXNM’s Senior Vice President and Chief Financial Officer (Principal Financial Officer), effective as of May 19, 2025, following Ms. Eden’s retirement from such role.
the Board of Directors (the “Board”) of Lifeward Ltd. (the “Company”) approved the appointment of Mark Grant as the Company’s President and Chief Executive Officer, effective June 2, 2025
the Board of Directors of the Company (the “Board”) has appointed Daniel Heaf to serve as Chief Executive Officer of the Company, effective May 16, 2025
Gina Boswell ceased to serve as Chief Executive Officer of the Company effective as of May 16, 2025
Keith Gottesdiener, M.D. had resigned as President, Chief Executive Officer and principal executive officer of the Company, and as a member of the Board of Directors of the Company
the Board appointed Allan Reine, M.D., the Company’s Chief Financial Officer and principal financial officer, as Chief Executive Officer and principal executive officer of the Company
On May 16, 2025, Mr. Sergio L. Maiworm, Jr. informed the Board of Directors (the “Board”) of Talos Energy Inc. (the “Company”) that he was resigning from his position as Executive Vice President and Chief Financial Officer of the Company, effective as of June 27, 2025, to pursue a new opportunity.
In connection with and following Mr. Maiworm’s resignation, effective as of June 28, 2025, Mr. Gregory M. Babcock was appointed as Interim Chief Financial Officer to serve until a permanent Chief Financial Officer is appointed by the Board.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.